Cargando…
Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers
BACKGROUND: Novel and targetable mutations are needed for improved understanding and treatment of lung cancer in never-smokers. METHODS: Twenty-seven lung adenocarcinomas from never-smokers were sequenced by both exome and mRNA-seq with respective normal tissues. Somatic mutations were detected and...
Autores principales: | Sun, Zhifu, Wang, Liang, Eckloff, Bruce W, Deng, Bo, Wang, Yi, Wampfler, Jason A, Jang, JinSung, Wieben, Eric D, Jen, Jin, You, Ming, Yang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060138/ https://www.ncbi.nlm.nih.gov/pubmed/24894543 http://dx.doi.org/10.1186/1755-8794-7-32 |
Ejemplares similares
-
Erratum to: Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers
por: Sun, Zhifu, et al.
Publicado: (2017) -
Clinical biomarkers of pulmonary carcinoid tumors in never smokers via profiling miRNA and target mRNA
por: Deng, Bo, et al.
Publicado: (2014) -
Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never Smokers
por: Jang, Jin Sung, et al.
Publicado: (2015) -
Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers
por: Luo, Wenxin, et al.
Publicado: (2023) -
Comprehensive Profiling of lincRNAs in Lung Adenocarcinoma of Never Smokers Reveals Their Roles in Cancer Development and Prognosis
por: Li, Ying, et al.
Publicado: (2017)